| Authors: |
Tøndel C; Haukeland University Hospital, Department of Pediatrics and University of Bergen, Department of Clinical Science, Bergen, Norway., Jenum S; Oslo University Hospital, Department of Infectious Diseases, Oslo, Norway., Tonby K; Oslo University Hospital, Department of Infectious Diseases, Oslo, Norway; University of Oslo, Institute of Clinical Medicine, Oslo, Norway., Christensen EE; Oslo University Hospital, Department of Infectious Diseases, Oslo, Norway; University of Oslo, Institute of Clinical Medicine, Oslo, Norway., Cox RJ; University of Bergen, Department of Clinical Science, The Influenza Center, Bergen, Norway; Haukeland University Hospital, Department of Microbiology, Bergen, Norway., Onyango TB; University of Bergen, Department of Clinical Science, The Influenza Center, Bergen, Norway; Haukeland University Hospital, Department of Microbiology, Bergen, Norway., Skeie LG; Oslo University Hospital, Department of Infectious Diseases, Oslo, Norway., Robins H; Adaptive Biotechnologies, Seattle, WA, USA., Klinger M; Adaptive Biotechnologies, Seattle, WA, USA., Banbury B; Adaptive Biotechnologies, Seattle, WA, USA., Bello T; Adaptive Biotechnologies, Seattle, WA, USA., Osborne EJ; Adaptive Biotechnologies, Seattle, WA, USA., Jørgensen MJ; Nykode Therapeutics ASA, Oslo, Norway. Electronic address: Mjjorgensen@nykode.com., Pourpe S; Nykode Therapeutics ASA, Oslo, Norway., Leikfoss IS; Nykode Therapeutics ASA, Oslo, Norway., Jürgens T; Nykode Therapeutics ASA, Oslo, Norway., Wold H; Nykode Therapeutics ASA, Oslo, Norway., Torhaug S; Nykode Therapeutics ASA, Oslo, Norway., Makvandi-Nejad S; Nykode Therapeutics ASA, Oslo, Norway., Edo-Matas D; Nykode Therapeutics ASA, Oslo, Norway., Schjetne K; Nykode Therapeutics ASA, Oslo, Norway., Fredriksen AB; Nykode Therapeutics ASA, Oslo, Norway., Norheim G; Nykode Therapeutics ASA, Oslo, Norway., Dyrhol-Riise AM; Oslo University Hospital, Department of Infectious Diseases, Oslo, Norway; University of Oslo, Institute of Clinical Medicine, Oslo, Norway. |
